August 31, 2018 | 1:51 PM by Fahad Khalid

Glaukos (GKOS) – iStent inject for Glaucoma

It pays to do fundamental research. This bullish view was first presented in the 3Q2018 Quarterly Outlook on July 1 with the stock at $40.65. The stock is now at…

Continue Reading »

September 5, 2017 | 1:06 AM by Fahad Khalid

Weekend Research – September 4

Please Subscribe or Login to access premium content.

Password must meet the following requirements: